The Pharmacogenomic Splution to Biotech M&A

Abrams, Sandra Lea
October 2004
Investment Dealers' Digest;10/18/2004, Vol. 70 Issue 40, p13
Trade Publication
Focuses on the importance of pharmacogenetics to healthcare acquisitions. Business opportunity in pharmacogenetics; Consolidation between biotech and diagnostic companies; Occurrence of consolidation between biotech and diagnostic companies.


Related Articles

  • Wisconsin Group Collaborates on Healthcare Quality.  // Quality Progress;May2003, Vol. 36 Issue 5, p26 

    Reports on the collaboration of resources between healthcare providers and businesses in Wisconsin. Formation of the Wisconsin Collaborative for Healthcare Quality; Development of report measures verified by independent third parties. INSET: The FACE of Quality..

  • Winners and losers in merger mania. Niiler, Eric // Nature Biotechnology;Nov99, Vol. 17 Issue 11, p1058 

    Focuses on several merger and acquisition activities involving various biotechnology companies in the year 1999. Suggestion of industry analysts regarding the success and failure of these deals; Possibility of pharmaceutical companies to face trouble due to some deals; Failure of allergy...

  • No blue-sky returns. Jones, Llewellyn // Finance Week;04/27/2001, p48 

    Focuses on merger of South Africa's medical switching companies, Mediswitch and Q EDI. Predictions of blue-sky potential in the technology sector; Major winners in the battle for supremacy in the medical switching market; Similarity of a medical switch to any transactional switch in the...

  • For the record.  // Modern Healthcare;02/01/99, Vol. 29 Issue 5, p17 

    Presents news briefs on healthcare. Acquisition of Holt-Krock Clinic's assets by Spark Regional Medical Center in Fort Smith, Arkansas, under an agreement with PhyCor; Details on `The National Survey of American's Families,' by the Urban Institute in 1999; Sale of the Integrated Health...

  • Exiting this year and into the next.  // Nature Biotechnology;Dec2005, Vol. 23 Issue 12, p1451 

    The article comments on the merger and acquisition activities of biotechnology companies in 2005 in the U.S. According to Recombinant Capital company, from January to November, there have been 190 biotechnology mergers and acquisitions with a total value of 48.8 billion dollars. Big...

  • Research collaborations. Grisham, Julie // Nature Biotechnology;Feb2000, Vol. 18 Issue 2, p133 

    Presents information about collaborations between biotechnology companies to carry out various medical research as of February 2000. Companies the have collaborated to develop a treatment for respiratory disorders; Details of a medical research by the collaboration between Elan Corp. and Isis...

  • Biotech sector matures. O'Driscoll, Cath // ICIS Chemical Business;4/17/2006, Vol. 1 Issue 15, p33 

    The article reports on the performance of the global biotechnology industry as of April 2006. It discusses global revenues of publicly traded biotech companies in 2005. It mentions the recovery of Europe's biotech industry after several years of consolidation. It tackles the growth of the global...

  • Small company mergers—good for whom? Maybeck, Vanessa; Bains, William // Nature Biotechnology;Nov2006, Vol. 24 Issue 11, p1343 

    The article claims that small private biotechnology company mergers and acquisitions are not being used to bolster product pipelines and to diversify business opportunities in Great Britain. This suggests that private company mergers are mainly about shares rather than business, which supports...

  • DRIVEN TO LICENSE. Bonifant, Ben; Dombeck, Michael; Lugovoy, Alex // Pharmaceutical Executive;Feb2007, Vol. 27 Issue 2, p92 

    The article reports on the licensing deals and acquisitions of pharmaceutical and biotechnology industries. The gap in pipelines shown by large and small companies drive the acquisitions and licensing deals to replace revenue lost to generic competition. It is also due to intense competition for...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics